Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Determination of activated protein C resistance in anticoagulated and lupus positive patients.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Jul 2000

Ivey L M, Thom J Y, Ivey J G, Baker R I

Abstract excerpt

Clotting-based activated protein C (APC) assays have limitations when testing patients on oral anticoagulant (OA) therapy or with a lupus anticoagulant (LA). Predilution in factor V (FV)-deficient plasma and testing with phospholipid-rich Russell Viper venom (RVV)-based methods have been shown to be the most suitable methods when testing these patient groups, respectively. We evaluated a modified RVV based...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activated Protein C Resistance
Share to Anticoagulants

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Factor V

Share to Heparin

Share to Lupus Coagulation Inhibitor

Share to Protein C

Share to Protein S Deficiency

Share to Warfarin

Source

Identifiers

PMID: 10937805
DOI: 10.1097/00001721-200007000-00007

Genes

APC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Determination of activated protein C resistance in anticoagulated and lupus positive patients.PMID 10937805Read ↗

Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.Semantic proximity Read ↗

A comparison between two activated protein C resistance methods as routine diagnostic tests for factor V Leiden mutation.Semantic proximity Read ↗

The use of two different APC resistance assay systems provides optimal sensitivity and specificity for diagnosing genetic APC resistance.Semantic proximity Read ↗

Careful selection of sample dilution and factor-V-deficient plasma makes the modified activated protein C resistance test highly specific for the factor V Leiden mutation.Semantic proximity Read ↗

Use of a generally applicable tissue factor--dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant.Semantic proximity Read ↗

Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.Semantic proximity Read ↗

Factor V Leiden and activated protein C resistance.Semantic proximity Read ↗

Comparison of three activated protein C resistance tests in the risk assessment of venous thrombosis in non-carriers of the factor V Leiden mutation.Semantic proximity Read ↗

Congenital and acquired activated protein C resistance.Semantic proximity Read ↗

The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance.Semantic proximity Read ↗

Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance.Semantic proximity Read ↗

Congenital resistance to activated protein C in patients with lupus anticoagulants: evaluation of two functional assays.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.